Edgewise Therapeutics SG&A Expense (TTM) Analysis

Edgewise Therapeutics Inc (EWTX)

26.09 +0.10 (+0.38%) USD | NASDAQ | Sep 27, 16:00

26.06 -0.03 (-0.11%) After-Hours: 20:00

SG&A Expense (TTM) Chart

Historical SG&A Expense (TTM) Data

View and export this data back to 2020. Upgrade now.

Date	Value
June 30, 2024	26.33M
March 31, 2024	24.68M
December 31, 2023	23.45M
September 30, 2023	22.74M
June 30, 2023	21.44M
March 31, 2023	19.75M
December 31, 2022	17.63M
September 30, 2022	15.89M

Date	Value
June 30, 2022	14.72M
March 31, 2022	13.23M
December 31, 2021	11.03M
September 30, 2021	8.497M
June 30, 2021	5.706M
March 31, 2021	3.425M
December 31, 2020	2.209M

SG&A Expense Definition

SG&A expense (short for Selling, General and Administrative expense) is a line item on the income statement, though sometimes sales and marketing expenses are reported separately from general and administrative expenses.

Read full definition.

SG&A Expense (TTM) Range, Past 5 Years

2.209M

Minimum

Dec 2020

26.33M

Maximum

Jun 2024

15.38M

Average

15.89M

Median

Sep 2022

SG&A Expense (TTM) Benchmarks